Addressing Antimicrobial Resistance in Cancer Care: A Review of national cancer control plans and policy recommendations

AMR poses a serious and growing threat to effective cancer treatment and care. Despite its importance to cancer care outcomes, AMR is not addressed in most NCCPs. To safeguard the progress made in preventing and treating cancer, it is essential that cancer planners integrate AMR strategies into NCCPs as a
critical component. Aligning these plans with national and global AMR efforts is not only cost-effective but critical to ensuring the sustainability of cancer care.
Strengthening collaboration between the cancer and AMR communities will help bridge current gaps and protect patients. Without urgent and coordinated
action, the gains achieved in cancer control risk being reversed by the unchecked rise of AMR.